YVETTE MARTINEZ: Open Payments
NPI 1962913830 · CONVERSE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 23 payments from 12 companies in 2025. Trend: 2023 $1,097 · 2024 $1,436 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $324 |
| Verona Pharma, Inc. | 1 | $125 |
| Lilly USA, LLC | 3 | $58 |
| Amgen Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $46 |
| PFIZER INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| UROGEN PHARMA, INC. | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: FREESTYLE LIBRE 3, CARDIOMEMS, Ohtuvayre, OTEZLA, Wegovy, MOUNJARO, XIFAXAN, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
